Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of FOLD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Amicus Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 7.40%22.8M shares | −1.90 ppfrom 9.30% | Feb 5, 20252 filings | Apr 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Amicus Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 20263:42 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −10.00 ppfrom 10.00%Below 5% | Mar 13, 2026 | SEC |
| Feb 10, 202611:23 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 0.40%1.37M shares | −9.10 ppfrom 9.50%Below 5% | Dec 31, 2025 | SEC |
| Feb 9, 20263:18 PM ET | William Blair Investment Management, LLC | 13G/A | 3.40%10.6M shares | −1.80 ppfrom 5.20%Below 5% | Dec 31, 2025 | SEC |
| Dec 3, 202511:13 AM ET | Vanguard Group Inc | 13G/A | 10.00%30.9M shares | – | Nov 28, 2025 | SEC |
| Nov 14, 20259:06 AM ET | Avoro Capital Advisors LLCand 1 other | 13G/A | 4.87%15.0M shares | −1.83 ppfrom 6.70%Below 5% | Sep 30, 2025 | SEC |
| Nov 12, 20256:08 PM ET | William Blair Investment Management, LLC | 13G | 5.20%16.0M shares | +0.30 ppfrom 4.90% | Sep 30, 2025 | SEC |
| Aug 14, 20254:25 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 2.40%7.41M shares | −4.60 ppfrom 7.00%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:30 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 7.00%21.5M shares | −1.10 ppfrom 8.10% | Mar 31, 2025 | SEC |
| May 15, 20259:30 AM ET | Avoro Capital Advisors LLCand 1 other | 13G/A | 6.70%20.5M shares | – | Mar 31, 2025 | SEC |
| May 9, 20254:47 PM ET | William Blair Investment Management, LLC | 13G/A | 4.90%14.8M shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 23, 20258:14 PM ET | BlackRock, Inc. | 13G/A | 7.40%22.8M shares | −1.90 ppfrom 9.30% | Mar 31, 2025 | SEC |
| Feb 14, 20258:00 PM ET | Redmile Group, LLCand 1 other | 13G/A | 4.60%14.2M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20254:15 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 8.10%24.2M shares | – | Dec 31, 2024 | SEC |
| Feb 10, 202510:25 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 9.50%28.5M shares | – | Dec 31, 2024 | SEC |
| Feb 5, 20251:23 PM ET | BlackRock, Inc. | 13G/A | 9.30%27.9M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Amicus Therapeutics, Inc. shares.
No Form 144 notices for Amicus Therapeutics, Inc. are on file.